• Users Online: 175
  • Print this page
  • Email this page
Year : 2021  |  Volume : 5  |  Issue : 4  |  Page : 168-170

Failure of therapeutic enoxaparin to prevent massive deep vein thrombosis and cerebral venous sinus thrombosis in a pregnant patient with combined factor v leiden mutation and antithrombin iii deficiency

1 Department of Internal Medicine, Hamad General Hospital, HMC, Doha, Qatar
2 Department of Radiology, Hamad General Hospital, HMC, Doha, Qatar

Correspondence Address:
Dr. Husam Nabil Abduljabbar Al-Dubai
P.O. Box: 3050, Doha
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ljms.ljms_59_21

Rights and Permissions

Women with combined inherited thrombophilia are at high risk of developing thrombotic events, especially when they are pregnant. Low-molecular-weight (LMW) heparins are the preferable agents for anticoagulation during pregnancy. Despite the fact that they have been proven to be effective in the treatment and prevention of venous thromboembolism, thrombotic events can still happen. Here, we report a case of a 40-year-old white pregnant woman with combined factor V Leiden mutation and antithrombin III deficiency who developed massive deep vein thrombosis and cerebral venous sinus thrombosis despite being on therapeutic doses of enoxaparin.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded84    
    Comments [Add]    

Recommend this journal